Skip to content

BI 730357

DRUG10 trials

Sponsors

Boehringer Ingelheim

Conditions

Arthritis, PsoriaticHealthyHealthy VolunteersPsoriasis

Phase 1

To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers
CompletedNCT03004404
Boehringer IngelheimHealthy Volunteers
Start: 2017-01-12End: 2017-08-15Updated: 2023-08-16
This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357
CompletedNCT03279978
Boehringer IngelheimHealthy, Psoriasis
Start: 2018-01-09End: 2018-08-30Updated: 2024-12-19
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 730357 in the Blood
CompletedNCT03782987
Boehringer IngelheimHealthy
Start: 2019-01-10End: 2019-03-11Updated: 2023-07-12
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated
CompletedNCT03793621
Boehringer IngelheimHealthy
Start: 2019-01-21End: 2019-04-26Updated: 2023-07-12
A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet
CompletedNCT03804671
Boehringer IngelheimHealthy
Start: 2019-01-31End: 2019-03-26Updated: 2023-07-25
Evaluation of Photosafety of BI 730357 Compared to Placebo and the Known Photosensitizing Agent Ciprofloxacin
CompletedNCT04147260
Boehringer IngelheimHealthy
Start: 2019-11-06End: 2020-09-09Updated: 2023-07-17
A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body
CompletedNCT04590937
Boehringer IngelheimHealthy
Start: 2020-10-20End: 2021-01-11Updated: 2023-09-06
A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood
CompletedNCT04679948
Boehringer IngelheimHealthy
Start: 2020-12-21End: 2021-03-17Updated: 2023-08-14

Phase 2

Related Papers